Home > Healthcare > Medical Devices > Therapeutic Devices > Ophthalmic Eye Dropper Market
Ophthalmic Eye Dropper Market size was valued at USD 13.3 billion in 2023 and is estimated to grow at a CAGR of 6.3% between 2024 and 2032. Ophthalmic eye dropper, also known as an eye dropper, is a device used to deliver liquid medications or solutions into the eye. It is commonly used for various eye conditions and treatments such as dry eye disease, glaucoma, among others.
The increasing prevalence of various eye disorders have emerged as a significant driver for the market. For instance, according to the World Health Organization, in 2023, glaucoma ranks as the second leading cause of blindness globally, with an estimated 60 million suspected cases worldwide. Therefore, there is a rising need for effective treatments like eye drops to manage these complicated eye health issues.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Ophthalmic Eye Dropper Market Size in 2023: | USD 13.3 Billion |
Forecast Period: | 2024 to 2032 |
Forecast Period 2024 to 2032 CAGR: | 6.3% |
2032 Value Projection: | USD 22.9 Billion |
Historical Data for: | 2018 – 2023 |
No. of Pages: | 140 |
Tables, Charts & Figures: | 274 |
Segments covered: | Eye Dropper Type, Mode, Indication, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Furthermore, growing technological advancements in ophthalmic drug delivery systems, rising ophthalmic ultrasound systems which is set to reach USD 1.3 billion by 2032, increasing geriatric population coupled with disease, increasing awareness and diagnosis, rising ophthalmic devices, and preference for non-invasive treatment options, among other contributing factors propelling the market growth.